These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10365666)

  • 1. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.
    Tam YK; Maki G; Miyagawa B; Hennemann B; Tonn T; Klingemann HG
    Hum Gene Ther; 1999 May; 10(8):1359-73. PubMed ID: 10365666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
    Zhang J; Sun R; Wei H; Zhang J; Tian Z
    Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
    Tam YK; Martinson JA; Doligosa K; Klingemann HG
    Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.
    Tam YK; Miyagawa B; Ho VC; Klingemann HG
    J Hematother; 1999 Jun; 8(3):281-90. PubMed ID: 10417052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
    Nagashima S; Mailliard R; Kashii Y; Reichert TE; Herberman RB; Robbins P; Whiteside TL
    Blood; 1998 May; 91(10):3850-61. PubMed ID: 9573023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
    Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
    Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
    Törnroos H; Hägerstrand H; Lindqvist C
    Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
    Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
    BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells.
    Konstantinidis KV; Alici E; Aints A; Christensson B; Ljunggren HG; Dilber MS
    Exp Hematol; 2005 Feb; 33(2):159-64. PubMed ID: 15676209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy.
    Zhang J; Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2004 Mar; 89(3):338-47. PubMed ID: 15020274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
    Jiang W; Zhang C; Tian Z; Zhang J
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R; Bockstoce DC; Golub SH
    Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.